{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:54:06Z","timestamp":1768895646966,"version":"3.49.0"},"posted":{"date-parts":[[2024,5,14]]},"group-title":"Biochemistry","reference-count":48,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Resistance to amikacin and other major aminoglycosides is commonly due to enzymatic acetylation by aminoglycoside 6\u2032-\n                  <jats:italic>N<\/jats:italic>\n                  -acetyltransferase type I enzyme, of which type Ib [AAC(6\u2032)-Ib] is the most widespread among Gram-negative pathogens. Finding enzymatic inhibitors could be an effective way to overcome resistance and extend the useful life of amikacin. Small molecules possess multiple properties that make them attractive compounds to be developed as drugs. Mixture-based combinatorial libraries and positional scanning strategy led to the identification of a chemical scaffold, pyrrolidine pentamine, that, when substituted with the appropriate functionalities at five locations (R1 - R5), inhibits AAC(6\u2032)-Ib-mediated inactivation of amikacin. Structure-activity relationship (SAR) studies showed that while truncations to the molecule result in loss of inhibitory activity, modifications of functionalities and stereochemistry have different effects on the inhibitory properties. In this study, we show that alterations at position R1 of the two most active compounds,\n                  <jats:bold>2700.001<\/jats:bold>\n                  and\n                  <jats:bold>2700.003<\/jats:bold>\n                  , reduced inhibition levels, demonstrating the essential nature not only of the presence of an\n                  <jats:italic>S<\/jats:italic>\n                  -phenyl moiety at this location but also the distance to the scaffold. On the other hand, modifications on the R3, R4, and R5 positions have varied effects, demonstrating the potential for optimization. A correlation analysis between molecular docking values (\u0394G) and the dose required for two-fold potentiation of compounds described in this and the previous studies showed a significant correlation between \u0394G values and inhibitory activity.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Highlights<\/jats:title>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>Amikacin resistance in Gram-negatives is mostly caused by the AAC(6\u2032)-Ib enzyme<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>AAC(6\u2032)-Ib has been identified in most Gram-negative pathogens<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Inhibitors of AAC(6\u2032)-Ib could be used to treat resistant infections<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Combinatorial libraries and positional scanning identified an inhibitor<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>The lead compound can be optimized by structure activity relationship studies<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>","DOI":"10.1101\/2024.05.14.594018","type":"posted-content","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T01:10:18Z","timestamp":1715735418000},"source":"Crossref","is-referenced-by-count":0,"title":["Structure-activity relationship of pyrrolidine pentamine derivatives as inhibitors of the aminoglycoside 6\u2032-\n                  <i>N<\/i>\n                  -acetyltransferase type Ib"],"prefix":"10.64898","author":[{"given":"Jan","family":"Sklenicka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-7890","authenticated-orcid":false,"given":"Maria S.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley M.","family":"Donow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel J.","family":"Maga\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"LaVoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir","family":"Mamun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0999-4975","authenticated-orcid":false,"given":"Prem","family":"Chapagain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radleigh","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemencia","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Giulianotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6298-7811","authenticated-orcid":false,"given":"Marcelo E.","family":"Tolmasky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024051804250783000_2024.05.14.594018v1.1","first-page":"65","article-title":"Bad bugs, no drugs 2002-2020: progress, challenges, and call to action","volume":"131","year":"2020","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2024051804250783000_2024.05.14.594018v1.2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab295"},{"key":"2024051804250783000_2024.05.14.594018v1.3","unstructured":"Centers-for-Disease-Control-and-Prevention. Antibiotic resistance threats in the United States. Atlanta, GA2019."},{"key":"2024051804250783000_2024.05.14.594018v1.4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02171-20"},{"key":"2024051804250783000_2024.05.14.594018v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06873-0"},{"key":"2024051804250783000_2024.05.14.594018v1.6","doi-asserted-by":"crossref","unstructured":"Tolmasky ME. Strategies to prolong the useful life of existing antibiotics and help overcoming the antibiotic resistance crisis In: Atta-ur-Rhaman , editor. Frontiers in Clinical Drug Research-Anti Infectives. Sharjah, UAE: Bentham Books; 2017. p. 1\u201327.","DOI":"10.2174\/9781681084879117040003"},{"key":"2024051804250783000_2024.05.14.594018v1.7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027029"},{"key":"2024051804250783000_2024.05.14.594018v1.8","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.3.430-450.2003"},{"key":"2024051804250783000_2024.05.14.594018v1.9","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200900779"},{"key":"2024051804250783000_2024.05.14.594018v1.10","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22122267"},{"key":"2024051804250783000_2024.05.14.594018v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2010.08.003"},{"key":"2024051804250783000_2024.05.14.594018v1.12","doi-asserted-by":"publisher","DOI":"10.3390\/life12121949"},{"key":"2024051804250783000_2024.05.14.594018v1.13","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.13.80"},{"key":"2024051804250783000_2024.05.14.594018v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.06.009"},{"key":"2024051804250783000_2024.05.14.594018v1.15","doi-asserted-by":"crossref","unstructured":"Tolmasky ME. Aminoglycoside-modifying enzymes: characteristics, localization, and dissemination. In: Bonomo RA , Tolmasky ME , editors. Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition. Washington, DC: ASM Press; 2007. p. 35\u201352.","DOI":"10.1128\/9781555815615.ch4"},{"key":"2024051804250783000_2024.05.14.594018v1.16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00121"},{"key":"2024051804250783000_2024.05.14.594018v1.17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3296-3304.2003"},{"key":"2024051804250783000_2024.05.14.594018v1.18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00129-14"},{"key":"2024051804250783000_2024.05.14.594018v1.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0906529106"},{"key":"2024051804250783000_2024.05.14.594018v1.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217602"},{"key":"2024051804250783000_2024.05.14.594018v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106442"},{"key":"2024051804250783000_2024.05.14.594018v1.22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010029"},{"key":"2024051804250783000_2024.05.14.594018v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.01.019"},{"key":"2024051804250783000_2024.05.14.594018v1.24","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091218"},{"key":"2024051804250783000_2024.05.14.594018v1.25","doi-asserted-by":"publisher","DOI":"10.1039\/C2MD00253A"},{"key":"2024051804250783000_2024.05.14.594018v1.26","doi-asserted-by":"publisher","DOI":"10.1039\/d3md00226h"},{"key":"2024051804250783000_2024.05.14.594018v1.27","doi-asserted-by":"publisher","DOI":"10.1039\/c8md90019a"},{"key":"2024051804250783000_2024.05.14.594018v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2011.10.018"},{"key":"2024051804250783000_2024.05.14.594018v1.29","doi-asserted-by":"publisher","DOI":"10.3390\/biom10050720"},{"key":"2024051804250783000_2024.05.14.594018v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(03)69018-X"},{"key":"2024051804250783000_2024.05.14.594018v1.31","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.05.556435"},{"key":"2024051804250783000_2024.05.14.594018v1.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-013-0326-5"},{"key":"2024051804250783000_2024.05.14.594018v1.33","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01304-15"},{"key":"2024051804250783000_2024.05.14.594018v1.34","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00212-15"},{"key":"2024051804250783000_2024.05.14.594018v1.35","unstructured":"Hoel DG. Statistical aspects of chemical mixtures. In: Vouk VB , Butler GC , Upton AC , Parke DV , Asher SC , editors. Methods for Assessing the Effects of Mixtures of Chemicals. New York, NY: Wiley; 1987. p. 369\u201377."},{"key":"2024051804250783000_2024.05.14.594018v1.36","doi-asserted-by":"publisher","DOI":"10.1021\/bi800664x"},{"key":"2024051804250783000_2024.05.14.594018v1.37","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21256"},{"key":"2024051804250783000_2024.05.14.594018v1.38","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33"},{"key":"2024051804250783000_2024.05.14.594018v1.39","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"2024051804250783000_2024.05.14.594018v1.40","doi-asserted-by":"publisher","DOI":"10.1021\/ci200227u"},{"key":"2024051804250783000_2024.05.14.594018v1.41","unstructured":"Schr\u00f6dinger L. The PyMOL Molecular Graphics System, Version 1.8. 2015."},{"key":"2024051804250783000_2024.05.14.594018v1.42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix211"},{"key":"2024051804250783000_2024.05.14.594018v1.43","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1660772"},{"key":"2024051804250783000_2024.05.14.594018v1.44","doi-asserted-by":"publisher","DOI":"10.1002\/bip.10398"},{"key":"2024051804250783000_2024.05.14.594018v1.45","doi-asserted-by":"publisher","DOI":"10.1021\/jm990174v"},{"key":"2024051804250783000_2024.05.14.594018v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114698"},{"key":"2024051804250783000_2024.05.14.594018v1.47","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.0c00184"},{"key":"2024051804250783000_2024.05.14.594018v1.48","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00261"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.05.14.594018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:26:27Z","timestamp":1768458387000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.05.14.594018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1101\/2024.05.14.594018","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.3390\/antibiotics13070672","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,5,14]]},"subtype":"preprint"}}